Pembrolizumab vs docetaxel for previously treated advanced NSCLC with a PD-L1 tumor proportion score (TPS) 1%-49%; Results from KEYNOTE-010.

Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/32842

Title:	Pembrolizumab vs docetaxel for previously treated advanced NSCLC with a PD-L1 tumor proportion score (TPS) 1%-49%; Results from KEYNOTE-010.
Authors:	GARON, Edward B.; HERBST, Roy S.; KIM, Dong-Wan; FELIP, Enriqueta; PEREZ-GRACIA, Jose Luis; HAN, Ji-Youn; KIM, Joo-Hang; ARVIS, Catherine Dubos; AHN, Myung-Ju; MAJEM, Margarita; FIDLER, Mary J.; GUBENS, Matthew A.; CASTRO, Gilberto; GARRIDO, Marcelo; SHENTU, Yue; IM, Ellie; LUBINIECKI, Gregory M.; BAAS, Paul
Citation:	JOURNAL OF CLINICAL ONCOLOGY, v.34, n.15, suppl.S, 2016
Appears in Collections:	Comunicações em Eventos - HC/ICESP Instituto do Câncer do Estado de São Paulo - HC/ICESP Comunicações em Eventos - LIM/24 LIM/24 - Laboratório de Oncologia Experimental

Files in This Item:

There are no files associated with this item.